Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Authors

S. Adams, P. Schmid, H.S. Rugo, E.P. Winer, D. Loirat, A. Awada, D.W. Cescon, H. Iwata, M. Campone, R. Nanda, R. Hui, G. Curigliano, D. Toppmeyer, J. O’Shaughnessy, S. Loi, S. Paluch-Shimon, A.R. Tan, D. Card, J. Zhao, V. Karantza, J. Cortés